6:30 AM SIGN-IN & BREAKFAST • 7:00 AM - 8:30 AM

BANDOL 1 (NEW WYNN SPACE)

CE: A Review of Psoriatic Arthritis Therapies for Specialty Pharmacists and Payers

Psoriatic arthritis is an inflammatory form of arthritis, affecting approximately 30% of patients with psoriasis. Up to 60% of patients with psoriatic arthritis experience progressive, erosive, and deforming joint damage. Early intervention is critical to improving clinical outcomes in psoriatic arthritis. The introduction of biologic agents, usually in combination with oral small molecules, have changed the treatment landscape. Despite advances in therapy, some patients do not respond to oral small molecules or anti-TNF-α. Newer classes of biologics have emerged, targeting interleukin (IL)-17, IL-23/23, and JAK molecules to address this unmet need. This live program features a clinical expert in psoriatic arthritis and a specialty pharmacist to review the pathophysiology and burden of psoriatic arthritis, examine clinical data for current and emerging therapies, investigate the costs associated with psoriatic arthritis, and explore how specialty pharmacists can better help patients with psoriatic arthritis.

Speakers

Jamie McConaha

Geoffrey Wall

Asembia

200 Park Avenue, Suite 300 
Florham Park, NJ 07932

973.564.8004

asembia.com

info@asembiasummit.com

SIGN UP FOR SUMMIT UPDATES

Asembia's Specialty Pharmacy Summit is a PRIVATE EVENT. Asembia reserves the right to deny registration and refuse access at our absolute and sole discretion for any reason whatsoever.

© 2020 Asembia Specialty Pharmacy Summit, LLC. All rights reserved.

CONNECT WITH US

  • Asembia LinkedIn
  • Asembia Twitter
  • Asembia Instagram
  • Asembia Facebook
  • Asembia Videos
  • Asembia Photos
2021Summit_Logo_White.png